BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23734661)

  • 21. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
    Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT
    J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product.
    Mulligan-Kehoe MJ; Wagner R; Wieland C; Powell R
    J Biol Chem; 2001 Mar; 276(11):8588-96. PubMed ID: 11113116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of beta-strand 5A of plasminogen activator inhibitor-1 in regulation of its latency transition and inhibitory activity by vitronectin.
    Jensen S; Kirkegaard T; Pedersen KE; Busse M; Preissner KT; Rodenburg KW; Andreasen PA
    Biochim Biophys Acta; 2002 Jun; 1597(2):301-10. PubMed ID: 12044908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteinase specificity and functional diversity in point mutants of plasminogen activator inhibitor 1.
    Gils A; Declerck PJ
    J Biol Chem; 1997 May; 272(19):12662-6. PubMed ID: 9139722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redirection of the reaction between activated protein C and a serpin to the substrate pathway.
    Komissarov AA; Andreasen PA; Declerck PJ; Kamikubo Y; Zhou A; Gruber A
    Thromb Res; 2008; 122(3):397-404. PubMed ID: 18045665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites.
    Ji HL; Zhao R; Komissarov AA; Chang Y; Liu Y; Matthay MA
    J Biol Chem; 2015 Feb; 290(9):5241-55. PubMed ID: 25555911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
    Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB
    Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a plasminogen activator inhibitor-1 variant without measurable affinity to vitronectin but otherwise normal.
    Jensen JK; Durand MK; Skeldal S; Dupont DM; Bødker JS; Wind T; Andreasen PA
    FEBS Lett; 2004 Jan; 556(1-3):175-9. PubMed ID: 14706846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated conversion of human plasminogen activator inhibitor-1 to its latent form by antibody binding.
    Verhamme I; Kvassman JO; Day D; Debrock S; Vleugels N; Declerck PJ; Shore JD
    J Biol Chem; 1999 Jun; 274(25):17511-7. PubMed ID: 10364183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of the hinge region between alpha-helix F and the main part of serpins, based upon identification of the epitope of plasminogen activator inhibitor type 1 neutralizing antibodies.
    Bijnens AP; Gils A; Knockaert I; Stassen JM; Declerck PJ
    J Biol Chem; 2000 Mar; 275(9):6375-80. PubMed ID: 10692438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
    Kjøller L; Kanse SM; Kirkegaard T; Rodenburg KW; Rønne E; Goodman SL; Preissner KT; Ossowski L; Andreasen PA
    Exp Cell Res; 1997 May; 232(2):420-9. PubMed ID: 9168821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.
    Schroeck F; Arroyo de Prada N; Sperl S; Schmitt M; Viktor M
    Biol Chem; 2002; 383(7-8):1143-9. PubMed ID: 12437099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activator.
    van Meijer M; Stoop A; Smilde A; Preissner KT; van Zonneveld AJ; Pannekoek H
    Thromb Haemost; 1997 Mar; 77(3):516-21. PubMed ID: 9066004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of serpin reaction through stabilization of transient intermediate by ligands bound to alpha-helix F.
    Komissarov AA; Zhou A; Declerck PJ
    J Biol Chem; 2007 Sep; 282(36):26306-15. PubMed ID: 17613529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abrogation of plasminogen activator inhibitor-1-vitronectin interaction ameliorates acute kidney injury in murine endotoxemia.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    PLoS One; 2015; 10(3):e0120728. PubMed ID: 25799354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a functional epitope in plasminogen activator inhibitor-1, not localized in the reactive center loop.
    Debrock S; Declerck PJ
    Thromb Haemost; 1998 Mar; 79(3):597-601. PubMed ID: 9531048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural determinants in the stability of the serpin/proteinase complex.
    De Taeye B; Verbeke K; Compernolle G; Biesemans W; Gils A; Declerck PJ
    Biochem Biophys Res Commun; 2003 Aug; 307(3):529-34. PubMed ID: 12893254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin.
    Koschnick S; Konstantinides S; Schäfer K; Crain K; Loskutoff DJ
    J Thromb Haemost; 2005 Oct; 3(10):2290-5. PubMed ID: 16194205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.